We reviewed the COVID-19 vaccines that reached phase III of clinical development. For each of the 10 vaccines identified, we described the technology used for vaccine development, the available data from phase III clinical trials, data on vaccine safety, and the role of new SARS-CoV-2 variants on vaccine efficacy.
The author(s) received no specific funding for this work
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.
Eladely, Ahmed A.; Anwer, Javaria MBBS; Gotimukul, Ashwini MBBS; KC, Manish MBBS; Petrey, Jessica MSLS; Glynn, Alex MA; Carrico, Ruth M. PhD, DNP; and Ramirez, Julio A. MD
"An Update on the Leading COVID-19 Vaccines,"
The University of Louisville Journal of Respiratory Infections: Vol. 5
, Article 2.
Available at: https://ir.library.louisville.edu/jri/vol5/iss1/2